{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:16:41Z","timestamp":1790648201171,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Adaptive enrichment designs involve preplanned rules for modifying enrolment criteria based on accruing data in a randomized trial. We focus on designs where the overall population is partitioned into two predefined subpopulations, e.g. based on a biomarker or risk score measured at baseline. The goal is to learn which populations benefit from an experimental treatment. Two critical components of adaptive enrichment designs are the decision rule for modifying enrolment, and the multiple-testing procedure. We provide a general method for simultaneously optimizing these components for two-stage, adaptive enrichment designs. We minimize the expected sample size under constraints on power and the familywise type I error rate. It is computationally infeasible to solve this optimization problem directly because of its non-convexity. The key to our approach is a novel, discrete representation of this optimization problem as a sparse linear program, which is large but computationally feasible to solve by using modern optimization techniques. We provide an R package that implements our method and is compatible with linear program solvers in several software languages. Our approach produces new, approximately optimal trial designs.<\/jats:p>","DOI":"10.1111\/rssb.12366","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T10:20:30Z","timestamp":1587118830000},"page":"749-772","source":"Crossref","is-referenced-by-count":14,"title":["Optimal, Two-Stage, Adaptive Enrichment Designs for Randomized Trials, using Sparse Linear Programming"],"prefix":"10.1093","volume":"82","author":[{"given":"Michael","family":"Rosenblum","sequence":"first","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health , Baltimore , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan X.","family":"Fang","sequence":"additional","affiliation":[{"name":"Pennsylvania State University , University Park , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[{"name":"Northwestern University , Evanston , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/01621459.1983.10477936","article-title":"Experimental design for binary data","volume":"78","author":"Abdelbasit","year":"1983","journal-title":"J. Am. Statist. Ass."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/1747493017701147","article-title":"A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (defuse 3)","volume":"12","author":"Albers","year":"2017","journal-title":"Int. J. Stroke"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-3758(78)90017-4","article-title":"On partial sufficiency: a review","volume":"2","author":"Basu","year":"1978","journal-title":"J. Statist. Planng Inf."},{"key":"2023022408364231600_","first-page":"130","article-title":"Multistage testing with adaptive designs (with discussion)","volume":"20","author":"Bauer","year":"1989","journal-title":"Biometr. Inform. Med. Biol."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2307\/2533441","article-title":"Evaluations of experiments with adaptive interim analyses","volume":"50","author":"Bauer","year":"1994","journal-title":"Biometrics"},{"key":"2023022408364231600_","volume-title":"Dynamic Programming and Optimal Control","author":"Bertsekas","year":"2017"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pst.1599","article-title":"Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements","volume":"12","author":"Boessen","year":"2013","journal-title":"Pharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sim.3559","article-title":"Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology","volume":"28","author":"Brannath","year":"2009","journal-title":"Statist. Med."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/bimj.200510232","article-title":"Confirmatory seamless phase ii\/iii clinical trials with hypotheses selection at interim: general concepts","volume":"48","author":"Bretz","year":"2006","journal-title":"Biometr. J."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Statist. Ass."},{"key":"2023022408364231600_","article-title":"Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design","author":"European Medicines Agency","year":"2007"},{"key":"2023022408364231600_","first-page":"1085","article-title":"Adaptively changing subgroup proportions in clinical trials","volume":"7","author":"Follmann","year":"1997","journal-title":"Statist. Sin."},{"key":"2023022408364231600_","article-title":"Guidance for industry: Adaptive designs for medical device clinical studies","author":"Food and Drug Administration","year":"2016"},{"key":"2023022408364231600_","article-title":"Guidance for industry: Adaptive design clinical trials for drugs and biologics","author":"Food and Drug Administration","year":"2019"},{"key":"2023022408364231600_","article-title":"E9 statistical principles for clinical trials","author":"Food and Drug Administration and European Medicines Agency","year":"1998"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1158\/1078-0432.CCR-05-0605","article-title":"Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients","volume":"11","author":"Freidlin","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2012.48.3826","article-title":"Phase iii clinical trials that integrate treatment and biomarker evaluation","volume":"31","author":"Freidlin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/sim.5541","article-title":"A conditional error function approach for subgroup selection in adaptive clinical trials","volume":"31","author":"Friede","year":"2012","journal-title":"Statist. Med."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-01689-9","volume-title":"Computation of Multivariate Normal and t Probabilities","author":"Genz","year":"2009"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1080\/10543406.2014.929583","article-title":"Improving probabilities of correct interim decision in population enrichment designs","volume":"25","author":"G\u00f6tte","year":"2015","journal-title":"J. Biopharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bimj.201300257","article-title":"Adaptive designs for subpopulation analysis optimizing utility functions","volume":"57","author":"Graf","year":"2015","journal-title":"Biometr. J."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/sim.6316","article-title":"Optimizing the data combination rule for seamless phase II\/III clinical trials","volume":"34","author":"Hampson","year":"2015","journal-title":"Statist. Med."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316672","volume-title":"Multiple Comparison Procedures","author":"Hochberg","year":"1987"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/pst.472","article-title":"An adaptive seamless phase ii\/iii design for oncology trials with subpopulation selection using correlated survival endpoints","volume":"10","author":"Jenkins","year":"2011","journal-title":"Pharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/10543400701645215","article-title":"Adaptive seamless designs: selection and prospective testing of hypotheses","volume":"17","author":"Jennison","year":"2007","journal-title":"J. Biopharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.TPS11081","article-title":"TAPPAS: an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS)","volume":"35","author":"Jones","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1747493017710341","article-title":"Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods","volume":"12","author":"Jovin","year":"2017","journal-title":"Int. J. Stroke"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.3390\/ijms160510354","article-title":"Optimal decision rules for biomarker-based subgroup selection for a targeted therapy in oncology","volume":"16","author":"Krisam","year":"2015","journal-title":"Int. J. Molec. Sci."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cct.2014.09.001","article-title":"Adaptive choice of patient subgroup for comparing two treatments","volume":"39","author":"Lai","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jspi.2013.07.010","article-title":"Information in a two-stage adaptive optimal design","volume":"144","author":"Lane","year":"2014","journal-title":"J. Statist. Planng Inf."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.0006-341X.1999.01286.x","article-title":"Adaptive sample size calculations in group sequential trials","volume":"55","author":"Lehmacher","year":"1999","journal-title":"Biometrics"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1467-9868.00304","article-title":"Detection of interactions in experiments on large numbers of factors (with discussion)","volume":"63","author":"Lewis","year":"2001","journal-title":"J. R. Statist. Soc."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/biomet\/63.3.655","article-title":"On closed testing procedures with special reference to ordered analysis of variance","volume":"63","author":"Marcus","year":"1976","journal-title":"Biometrika"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/annonc\/mdy464","article-title":"An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)","volume":"30","author":"Mehta","year":"2019","journal-title":"Ann. Oncol."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/biomet\/asr055","article-title":"Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment","volume":"98","author":"Rosenblum","year":"2011","journal-title":"Biometrika"},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/01621459.2013.879063","article-title":"Optimal tests of treatment effects for the overall population and two subpopulations in randomized trials, using sparse linear programming","volume":"109","author":"Rosenblum","year":"2014","journal-title":"J. Am. Statist. Ass."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<455::AID-SIM382>3.0.CO;2-Y","article-title":"Evaluating treatments when a gender by treatment interaction may exist","volume":"16","author":"Russek-Cohen","year":"1997","journal-title":"Statist. Med."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/bimj.200510231","article-title":"Confirmatory seamless phase ii\/iii clinical trials with hypotheses selection at interim: applications and practical considerations","volume":"48","author":"Schmidli","year":"2006","journal-title":"Biometr. J."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10543406.2013.857238","article-title":"Adaptive designs for confirmatory clinical trials with subgroup selection","volume":"24","author":"Stallard","year":"2014","journal-title":"J. Biopharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bimj.200900003","article-title":"Adaptive patient enrichment designs in therapeutic trials","volume":"51","author":"Wang","year":"2009","journal-title":"Biometr. J."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pst.300","article-title":"Approaches to evaluation of treatment effect in randomized clinical trials with genomic subsets","volume":"6","author":"Wang","year":"2007","journal-title":"Pharm. Statist."},{"key":"2023022408364231600_","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1002\/sim.5513","article-title":"Optimal design of multi-arm multi-stage trials","volume":"31","author":"Wason","year":"2012","journal-title":"Statist. Med."}],"container-title":["Journal of the Royal Statistical Society Series B: Statistical Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Frssb.12366","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jrsssb\/article-pdf\/82\/3\/749\/49323709\/jrsssb_82_3_749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrsssb\/article-pdf\/82\/3\/749\/49323709\/jrsssb_82_3_749.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T01:40:03Z","timestamp":1696038003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrsssb\/article\/82\/3\/749\/7056063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,4,17]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/rssb.12366","relation":{},"ISSN":["1369-7412","1467-9868"],"issn-type":[{"value":"1369-7412","type":"print"},{"value":"1467-9868","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,4,17]]}}}